Prospective Study
Copyright ©The Author(s) 2021.
World J Radiol. Oct 28, 2021; 13(10): 344-353
Published online Oct 28, 2021. doi: 10.4329/wjr.v13.i10.344
Table 1 The total number and types of cancers that were included in our patient population
Type of cancer
Total number
Lymphoma61
Lung54
Breast53
Head and neck12
Thyroid10
Colon9
Melanoma9
Multiple myeloma9
Endometrial6
Pancreas5
Bladder5
Prostate4
Kidney3
Sarcoma3
Esophageal3
Other124
Table 2 Standard uptake value measurements of right and left shoulders in symptomatic and asymptomatic patients
Left shoulderTotal (n = 200)Asymptomatic (n = 143)Symptomatic (n = 57)P value
RI SUVmax1.7 ± 0.91.6 ± 0.72.0 ± 1.1< 0.001
RI SUVmean1.4 ± 0.71.3 ± 0.61.6 ± 0.90.002
Deltoid SUVmax0.9 ± 0.30.9 ± 0.31.0 ± 0.30.068
Deltoid SUVmean0.8 ± 0.30.8 ± 0.30.8 ± 0.30.281
Normalized SUVmax1.9 ± 1.31.9 ± 1.02.0 ± 1.50.125
Normalized SUVmean1.8 ± 1.21.8 ± 1.11.9 ± 1.60.112
Right shoulderTotal (n = 200)Asymptomatic (n = 143)Symptomatic (n = 57)P value
RI SUVmax1.9 ± 0.81.8 ± 0.82.2 ± 0.70.002
RI SUVmean1.5 ± 0.71.5 ± 0.71.8 ± 0.80.012
Deltoid SUVmax0.9 ± 0.30.9 ± 0.30.9 ± 0.30.279
Deltoid SUVmean0.7 ± 0.20.7 ± 0.20.8 ± 0.30.160
Normalized SUVmax2.2 ± 1.12.2 ± 1.12.3 ± 1.50.105
Normalized SUVmean2.1 ± 1.02.2 ± 1.02.1 ± 1.10.392
Table 3 Multiple linear regression analyses showing association between right or left shoulder standard uptake value measurements and symptom status after adjusting for covariates, stratified by cancer type
Cancer typeLeft RI SUVmaxRight RI SUVmax
Value95%CIValue95%CI
Breast0.36-0.37, 0.440.13-0.51, 0.54
Lung0.650.24, 1.070.560.14, 0.97
Lymphoma0.28-0.14, 0.700.08-0.34, 0.51
Multiple0.25-0.21, 0.710.23-0.01, 1.12
Other0.570.23, 0.910.22-0.21, 0.65
Cancer typeLeft RI SUVmeanRight RI SUVmean
Value95%CIValue95%CI
Breast0.05-0.30, 0.39-0.03-0.46, 0.41
Lung0.500.14, 0.860.450.11, 0.80
Lymphoma0.19-0.17, 0.55-0.06-0.42, 0.29
Multiple0.19-0.21, 0.580.45-0.02, 0.92
Other0.440.14, 0.730.28-0.08, 0.64